Curriculum vitae Dr. med. Johannes Forster
4/2004-4/2005 |
| ||||
4/2005-11/2011 | Medical Studies at Westfälischen Wilhelmsuniversität Münster (Germany), Université de Nantes (France) | ||||
4/2009-12/2012 | Doctoral Thesis, Institute of Tropical Medicine, Eberhard Karls Universität Tübingen MD awarded 2012 (magna cum laude) | ||||
3/2012-3/2017 | Specialist training in “Paediatrics and Adolescent Medicine”, St. Josef Hospital, Children’s Hospital Ruhr-University of Bochum (Germany) | ||||
5/2016 | Diploma in Tropical Medicine and Hygiene (DTMH, Liverpool, UK) | ||||
5/2017 | Board examination in „Paediatrics and Adolescent Medicine“ (Facharztprüfung “Kinder- und Jugendmedizin”), Ärztekammer Westfalen-Lippe | ||||
7/2017- 9/2021 | Specialist training in „Microbiology, Virology and Infection Epidemiology“, Institute for Hygiene and Microbiology, University of Würzburg | ||||
11/2021 | Board examination in „Microbiology, Virology and Infection Epidemiology“ (Facharztprüfung “Mikrobiologie, Virologie und Infektionsepidemiologie”), Bayerische Landesärztekammer | ||||
Research Fields | |||||
Diagnostic and clinical microbiology | |||||
Selected Publications | |||||
Dichtl, K., A. Osterman, J. Forster, L. Jakob, S. Suerbaum, M. J. Flaig, S. Schubert and J. Wagener (2023). "A retrospective evaluation of the Euroarray STI-11 multiplex system for the detection of eight STI causing agents." Sci Rep 13(1): 11382. Engels, G., K. Hecker, J. Forster, N. Toepfner, E. Hick, F. Pietsch, P. Heuschmann, R. Berner, C. Hartel, O. Kurzai, A. Petersmann, A. Streng and J. Liese (2022). "High Seroprevalence of SARS-CoV-2 in Preschool Children in July 2022." Dtsch Arztebl Int 119(45): 771-772. Forster, J., K. Dichtl and J. Wagener (2022). "Lower beta-1,3-D-glucan testing cut-offs increase sensitivity for non-albicans Candida species bloodstream infections." Mycoses 65(5): 500-507. Forster, J., M. Hoenigl, S. Suerbaum, J. Wagener and K. Dichtl (2022). "Serologic biomarkers in Candida and Aspergillus infections of the central nervous system: A comparison of galactomannan, mannan and β-1,3-D-gucan testing from serum and cerebrospinal fluid." Mycoses 65(7): 709-714. Forster, J., O. Koc, M. B. Koeppel, A. Hamprecht, O. Kurzai, S. Suerbaum, J. Wagener and K. Dichtl (2022). "beta-1,3-d-Glucan and Galactomannan as Biomarkers for the Detection of Invasive Geotrichum and Magnusiomyces Infections: a Retrospective Evaluation." J Clin Microbiol 60(1): e0160721. Forster, J., B. Kohlmorgen, J. Haas, P. Weis, L. Breunig, D. Turnwald, B. Mizaikoff and C. Schoen (2022). "A streamlined method for the fast and cost-effective detection of bacterial pathogens from positive blood cultures for the BacT/ALERT blood culture system using the Vitek MS mass spectrometer." PLoS One 17(4): e0267669. Forster, J., P. Paul and J. Liese (2023). "Current Management of Pediatric Parapneumonic Pleural Effusions and Pleural Empyema." Pediatr Infect Dis J 42(11): e407-e410. Forster, J., A. Streng, P. Rudolph, V. Rucker, J. Wallstabe, S. Timme, F. Pietsch, K. Hartmann, M. Krauthausen, J. Schmidt, T. Ludwig, D. Gierszewski, T. Jans, G. Engels, B. Weissbrich, M. Romanos, L. Dolken, P. Heuschmann, C. Hartel, I. Gagyor, M. T. Figge, O. Kurzai, J. Liese and V. S. G. Wu-KiTa-Co (2022). "Feasibility of SARS-CoV-2 Surveillance Testing Among Children and Childcare Workers at German Day Care Centers: A Nonrandomized Controlled Trial." JAMA Netw Open 5(1): e2142057. Forster, J., G. Piazza, D. Goettler, D. Kemmling, C. Schoen, M. Rose, A. Streng and J. G. Liese (2021). "Effect of Prehospital Antibiotic Therapy on Clinical Outcome and Pathogen Detection in Children With Parapneumonic Pleural Effusion/Pleural Empyema." Pediatr Infect Dis J 40(6): 544-549. Krone, M., I. Wagenhäuser, K. Knies, D. Hofmann, G. Engels, R. Taurines, M. McDonogh, S. Flemming, T. Meyer, H. Böhm, A. Scherzad, M. Eisenmann, V. Rauschenberger, A. Gabel, N. Petri, J. Reusch, J. Forster, B. Weißbrich, L. Dölken, O. Kurzai, U. Vogel, C. Härtel, J. Liese and O. Andres (2023). "Clinical accuracy of SARS-CoV-2 rapid antigen testing in screening children and adolescents." J Infect 86(3): 256-308. | |||||